Verena Wally - Search Results

Year	Number of Results
2006	1
2007	2
2008	2
2010	1
2011	1
2012	1
2013	5
2014	1
2015	2
2017	4
2018	6
2019	1
2020	3
2021	4
2022	6
2023	9
2024	3

1

Challenges and progress related to gene editing in rare skin diseases.

Piñón Hofbauer J, Guttmann-Gruber C, Wally V, Sharma A, Gratz IK, Koller U. Piñón Hofbauer J, et al. Among authors: wally v. Adv Drug Deliv Rev. 2024 May;208:115294. doi: 10.1016/j.addr.2024.115294. Epub 2024 Mar 23. Adv Drug Deliv Rev. 2024. PMID: 38527624 Free article. Review.

2

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Hainzl S, Trattner L, Liemberger B, Bischof J, Kocher T, Ablinger M, Nyström A, Obermayer A, Klausegger A, Guttmann-Gruber C, Wally V, Bauer JW, Hofbauer JP, Koller U. Hainzl S, et al. Among authors: wally v. Int J Mol Sci. 2024 Jan 7;25(2):761. doi: 10.3390/ijms25020761. Int J Mol Sci. 2024. PMID: 38255836 Free PMC article.

3

Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials.

Geroldinger M, Verbeeck J, Hooker AC, Thiel KE, Molenberghs G, Nyberg J, Bauer J, Laimer M, Wally V, Bathke AC, Zimmermann G. Geroldinger M, et al. Among authors: wally v. Orphanet J Rare Dis. 2023 Dec 19;18(1):391. doi: 10.1186/s13023-023-02990-1. Orphanet J Rare Dis. 2023. PMID: 38115074 Free PMC article.

4

MicroRNA-30d-5p-A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction.

Boxhammer E, Paar V, Wernly B, Kiss A, Mirna M, Aigner A, Acar E, Watzinger S, Podesser BK, Zauner R, Wally V, Ablinger M, Hackl M, Hoppe UC, Lichtenauer M. Boxhammer E, et al. Among authors: wally v. Cells. 2023 Sep 27;12(19):2369. doi: 10.3390/cells12192369. Cells. 2023. PMID: 37830583 Free PMC article.

5

Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting.

Korte EWH, Spuls PI, van den Akker PC, Kiritsi D, Laimer M, Pasmooij AMG, Riedl R, Vroom E, Wally V, Welponer T, Bolling MC. Korte EWH, et al. Among authors: wally v. Br J Dermatol. 2024 Jan 23;190(2):268-270. doi: 10.1093/bjd/ljad361. Br J Dermatol. 2024. PMID: 37792735 No abstract available.

6

MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.

Illmer J, Zauner R, Piñón Hofbauer J, Wimmer M, Gruner S, Ablinger M, Bischof J, Dorfer S, Hainzl S, Tober V, Bergson S, Sarig O, Samuelov L, Guttmann-Gruber C, Shalom-Feuerstein R, Sprecher E, Koller U, Laimer M, Bauer JW, Wally V. Illmer J, et al. Among authors: wally v. Br J Dermatol. 2023 Dec 20;190(1):80-93. doi: 10.1093/bjd/ljad335. Br J Dermatol. 2023. PMID: 37681509

7

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.

Zauner R, Wimmer M, Atzmueller S, Proell J, Niklas N, Ablinger M, Reisenberger M, Lettner T, Illmer J, Dorfer S, Koller U, Guttmann-Gruber C, Hofbauer JP, Bauer JW, Wally V. Zauner R, et al. Among authors: wally v. Cancers (Basel). 2023 Jun 22;15(13):3286. doi: 10.3390/cancers15133286. Cancers (Basel). 2023. PMID: 37444397 Free PMC article.

8

Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial.

Teng J, Paller AS, Bruckner AL, Murrell DF, Mellerio JE, Bodemer C, Martinez AE, Lugo-Somolinos A, Sprecher E, Laimer M, Wally V, Chan YM, Lin SY, Spellman M, Bauer JW. Teng J, et al. Among authors: wally v. J Drugs Dermatol. 2023 Jun 1;22(6):599-604. doi: 10.36849/JDD.7108. J Drugs Dermatol. 2023. PMID: 37276163 Clinical Trial.

9

Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization.

Korte EWH, Welponer T, Kottner J, van der Werf S, van den Akker PC, Horváth B, Kiritsi D, Laimer M, Pasmooij AMG, Wally V, Bolling MC. Korte EWH, et al. Among authors: wally v. Br J Dermatol. 2023 Jul 7;189(1):80-90. doi: 10.1093/bjd/ljad077. Br J Dermatol. 2023. PMID: 37098154 Review.

10

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.

Zwicklhuber J, Kocher T, Liemberger B, Hainzl S, Bischof J, Strunk D, Raninger AM, Gratz I, Wally V, Guttmann-Gruber C, Hofbauer JP, Bauer JW, Koller U. Zwicklhuber J, et al. Among authors: wally v. Int J Mol Sci. 2023 Mar 8;24(6):5197. doi: 10.3390/ijms24065197. Int J Mol Sci. 2023. PMID: 36982270 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year